Newborn screening study aims to catch rare diseases at birth
NCT ID NCT03655223
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and many others. The goal is to identify affected infants before symptoms appear, allowing for prompt treatment and support. Researchers also study the impact of screening on families and evaluate the program's effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this screening program could enable earlier diagnosis and treatment for newborns with rare conditions, potentially improving their health and development.
- What could go wrong
- This is an observational screening study, not a treatment trial. Most newborns will screen negative, and positive results may cause anxiety. The long-term benefits of early diagnosis are still being evaluated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 17 ALPHA-HYDROXYLASE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RTI International
Research Triangle Park, North Carolina, 27709, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a lower steroid dose preserve strength in young boys with DMD?
- A Once-a-Week shot could transform hemophilia Care—Even for those with inhibitors
- Can six short writing sessions ease PTSD in underserved patients?
- Hidden heart risks in Wilson's disease: a new scan could spot them early
- Gene Editing's lasting impact: a 10-Year safety watch
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?